Looks like QILU already partnered up with Arbutus ABUS in December 2021 to help develop their hep B drug, giving them 40 million upfront, 425 million in milestones, and double digit tiered royalties and a 15 million equity investment. How does this factor in with Cydy?
Also, I read a few weeks ago on the Facebook Cydy page where some posters were mentioning Cydy going private possibly. What would be the likelihood of that? Are there any signs of this on the horizon and what would that mean for us shareholders?